Linalyl acetate is the signature ester behind many lavender, petitgrain, bergamot, clary sage, and neroli profiles in the AromaForge archive. Public evidence strongly supports its identity, widespread occurrence, and fragrance safety review, while direct constituent-specific pharmacology is smaller but still meaningful: accessible studies describe anti-inflammatory activity, mast-cell-related signaling effects, and older animal sedation work. The evidence is still mostly preclinical, so the most accurate archive framing is that linalyl acetate is a high-value aroma and chemotype marker with early functional literature rather than a clinically established standalone active.
Chemical identity and composition
PubChem and NIST identify linalyl acetate as C12H20O2 with InChIKey UWKAYLJWKGQEPM-UHFFFAOYSA-N. As an ester of linalool and acetic acid, it is relevant both for scent profile and for toxicology because fragrance safety assessments treat hydrolysis to linalool and acetic acid as part of its metabolic context.
Aroma and practical use
- Use the recorded bergamot-like, lavender-like, sweet, floral descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
anti inflammatory activity
A 2003 constituent study concluded that both linalool and linalyl acetate played a major role in the anti-inflammatory activity attributed to several essential oils and found linalyl acetate to be active as an isolated constituent.
Measured: anti-inflammatory activity of isolated monoterpene constituents
This experimental finding does not establish benefit, dose or safety in people using this blend.
mast cell tslp signaling
A 2018 mast-cell paper reported that linalyl acetate reduced thymic stromal lymphopoietin production, adding direct constituent-level evidence for anti-inflammatory signaling effects in vitro.
Measured: TSLP production and inflammation-related signaling
This experimental finding does not establish benefit, dose or safety in people using this blend.
sedative mouse data
An older lavender constituent study reported that linalyl acetate showed sedative effects in mice, with reduced motility under standardized exposure conditions.
Measured: motility reduction after exposure
This experimental finding does not establish benefit, dose or safety in people using this blend.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedA 2024 RIFM update supports linalyl acetate for current fragrance uses and places the strongest public safety framing in the fragrance-risk-assessment context rather than therapeutic use.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
Because linalyl acetate can hydrolyze to linalool, oxidation and downstream allergen context should still be considered when archive users interpret aged or fragranced materials.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No strong constituent-specific human clinical safety literature for isolated linalyl acetate was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
LinaloolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
animal · effect
No source citation attached.
Read Linalool report →alpha-TerpineolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read alpha-Terpineol report →LimoneneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Limonene report →FarnesolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Farnesol report →LinaloolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
analytical · whole_oil
No source citation attached.
Read Linalool report →How the effects were investigated
reduced tslp and mast cell inflammatory outputs
A mast-cell study reported that linalyl acetate decreased TSLP production and other inflammatory outputs, supporting a constituent-level effect on allergic-inflammation signaling in vitro.
This experimental finding does not establish benefit, dose or safety in people using this blend.
ester hydrolysis context
Fragrance safety assessments treat linalyl acetate as an ester whose metabolic context includes hydrolysis to linalool and acetic acid, which is relevant to read-across toxicology interpretation.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- Most constituent-specific findings for isolated linalyl acetate are cell or animal studies rather than human trials.
- The public safety picture is better developed for fragrance exposure than for concentrated standalone dosing.
- Some relaxation or sleep literature involves whole lavender oil or mixed volatile fractions rather than isolated linalyl acetate alone.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.